CAUSEY CHRISTOPHER bought UTHR
September 24, 2025 · Form 4 insider transaction
CAUSEY CHRISTOPHER bought 1,000 shares of United Therapeutics Corporation at $119.76 per share, a transaction worth $119.8K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
1,000
Price
$119.76
Total value
$119.8K
InsiderCAUSEY CHRISTOPHER
RoleDirector
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateSeptember 24, 2025
Filing dateSeptember 25, 2025
Shares owned after5,865
OwnershipDirect
10b5-1 planNo
AmendedNo